Piperazine derivatives

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/208, 260/246

C07D 295/15 (2006.01) A61K 31/395 (2006.01) C07D 205/04 (2006.01) C07D 221/20 (2006.01) C07D 239/42 (2006.01) C07D 295/084 (2006.01) C07D 295/088 (2006.01) C07D 295/125 (2006.01) C07D 295/13 (2006.01) C07D 295/145 (2006.01) C07D 295/185 (2006.01) C07D 319/20 (2006.01) C07D 401/00 (2006.01) C07D 403/00 (2006.01) C07D 405/06 (2006.01) C07D 417/06 (2006.01)

Patent

CA 2015034

Piperazine derivatives of formula Image and their pharmaceutically acceptable acid addition salts are disclosed. Tn the formula n is 1 or 2, R is hydrogen or lower alkyl, R1 is an aryl or nitrogen containing heteroaryl radical, R2 is hydrogen or lower alkyl, R3 is aryl, C4-8 alkyl or aryl(lower)alkyl and X is a functionalised group of specified meaning. The compounds exhibit activity as 5-HT1A antagonists and can be used, into alia, for the treatment of CNS disorders, such as anxiety.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Piperazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1361391

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.